Trials / Conditions / Childhood Spinal Cord Neoplasm
Childhood Spinal Cord Neoplasm
5 registered clinical trials studyying Childhood Spinal Cord Neoplasm.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Tem NCT01236560 | National Cancer Institute (NCI) | Phase 2 / Phase 3 |
| Completed | Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medul NCT00381797 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma NCT00363272 | National Cancer Institute (NCI) | Phase 1 |
| Completed | AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors NCT00326664 | National Cancer Institute (NCI) | Phase 1 |
| Completed | FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia NCT00053963 | National Cancer Institute (NCI) | Phase 1 |